[Mechanism of action of cytostatic agents in rheumatoid arthritis].
D000328:Adult; D000906:Antibodies / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001327:Autoimmune Diseases / Q000175:diagnosis; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D008214:Lymphocytes; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009504:Neutrophils; D012217:Rheumatoid Factor / Q000032:analysis; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use
D000906:Antibodies; D000970:Antineoplastic Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D012217:Rheumatoid Factor; D013852:Thiotepa; D015122:Mercaptopurine
O mekhanizme deĭstviia tsitostaticheskikh sredstv pri revmatoidnom artrite